PSNL

3.16

0.94% -0.03

Dopo l'orario di chiusura: 3.16

Personalis Inc (PSNL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$3.19

Aprire:

$3.14

Volume 24 ore:

598.34K

Relative Volume:

0.61

Capitalizzazione di mercato:

$286.12M

Reddito:

$73.48M

Utile/perdita netta:

$-108.30M

Rapporto P/E:

-1.4044

EPS:

-2.25

Flusso di cassa netto:

$-67.17M

1 W Prestazione:

-2.47%

1M Prestazione:

-11.24%

6M Prestazione:

-33.75%

1 anno Prestazione:

+144.96%

Intervallo 1D:

$3.09

$3.32

Intervallo di 1 settimana:

$3.09

$3.38

Portata 52W:

$1.135

$7.20

Personalis Inc Stock (PSNL) Company Profile

Nome

Personalis Inc

Settore

Healthcare (1155)

Industria

Diagnostics & Research (59)

Telefono

650-752-1300

Indirizzo

6600 DUMBARTON CIRCLE, FREMONT, CA

Dipendente

229

Cinguettio

@PersonalisInc

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

PSNL's Discussions on Twitter

Confronta PSNL con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
PSNL Personalis Inc	3.16	286.12M	73.48M	-108.30M	-67.17M	-2.25
TMO Thermo Fisher Scientific Inc	421.85	169.62B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	184.96	138.06B	23.88B	3.90B	5.30B	5.28
IDXX Idexx Laboratories Inc	406.65	32.79B	3.90B	887.87M	798.08M	10.67
A Agilent Technologies Inc	100.26	29.99B	6.53B	1.26B	1.31B	4.35
IQV Iqvia Holdings Inc	141.22	26.61B	15.41B	1.37B	2.11B	7.50

Personalis Inc Stock (PSNL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-03-17	Iniziato	Craig Hallum	Buy
2023-02-06	Aggiornamento	Needham	Hold → Buy
2022-01-07	Aggiornamento	BofA Securities	Neutral → Buy
2021-11-05	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-11-03	Downgrade	Needham	Buy → Hold
2021-10-15	Ripresa	Cowen	Outperform
2021-09-20	Reiterato	Needham	Buy
2021-05-06	Aggiornamento	Oppenheimer	Perform → Outperform
2021-01-28	Iniziato	Truist	Buy
2021-01-04	Downgrade	BofA Securities	Buy → Neutral
2020-11-12	Reiterato	Needham	Buy
2020-11-06	Downgrade	Oppenheimer	Outperform → Perform
2020-10-19	Iniziato	Citigroup	Buy
2020-10-08	Iniziato	BTIG Research	Buy
2020-08-27	Iniziato	H.C. Wainwright	Buy
2020-08-18	Iniziato	Needham	Buy
2019-09-26	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-07-15	Iniziato	BofA/Merrill	Neutral
2019-07-15	Iniziato	Cowen	Outperform
2019-07-15	Iniziato	Morgan Stanley	Overweight
2019-07-15	Iniziato	Oppenheimer	Outperform

Mostra tutto

Personalis Inc Borsa (PSNL) Ultime notizie

Apr 21, 2025

Renaissance Technologies LLC Trims Stock Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World

Apr 21, 2025

Apr 15, 2025

Arrowstreet Capital Limited Partnership Lowers Stock Holdings in Personalis, Inc. (NASDAQ:PSNL) - Defense World

Apr 15, 2025

Apr 14, 2025

Raymond James Financial Inc. Buys New Stake in Personalis, Inc. (NASDAQ:PSNL) - Defense World

Apr 14, 2025

American Century Companies Inc. Buys 25,011 Shares of Personalis, Inc. (NASDAQ:PSNL) - Defense World

Apr 14, 2025

Apr 12, 2025

Needham & Company LLC Reiterates “Buy” Rating for Personalis (NASDAQ:PSNL) - Defense World

Apr 12, 2025

Apr 11, 2025

With 33% stake, Personalis, Inc. (NASDAQ:PSNL) seems to have captured institutional investors' interest - Yahoo Finance

Apr 11, 2025

Apr 10, 2025

What 5 Analyst Ratings Have To Say About Personalis - Benzinga

Apr 10, 2025

Mar 26, 2025

Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference - BioSpace

Mar 26, 2025

Mar 23, 2025

Personalis, Inc. (NASDAQ:PSNL) Shares Sold by Connor Clark & Lunn Investment Management Ltd. - Defense World

Mar 23, 2025

Mar 22, 2025

Personalis Inc’s (PSNL) Stock Is Harder To Predict Than You Think - Stocks Register

Mar 22, 2025

Mar 21, 2025

What You Can Learn From Personalis, Inc.'s (NASDAQ:PSNL) P/S After Its 40% Share Price Crash - simplywall.st

Mar 21, 2025

Mar 20, 2025

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 20, 2025

Mar 18, 2025

Personalis (NASDAQ:PSNL) Now Covered by Craig Hallum - Defense World

Mar 18, 2025

Mar 17, 2025

Craig-Hallum Initiates Coverage of Personalis (PSNL) with Buy Recommendation - Nasdaq

Mar 17, 2025

This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Mar 17, 2025

Craig Hallum Initiates Coverage on Personalis With Buy Rating, $8 Price Target -March 17, 2025 at 07:58 am EDT - Marketscreener.com

Mar 17, 2025

Mar 12, 2025

Hold Rating for Personalis: Balancing Strong Enterprise Sales and Future Uncertainties - TipRanks

Mar 12, 2025

Mar 08, 2025

Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip - Benzinga

Mar 08, 2025

Mar 07, 2025

Personalis Stock Price, Quotes and Forecasts | NASDAQ:PSNL - Benzinga

Mar 07, 2025

Mar 03, 2025

Personalis stock target cut to $7 by BTIG, maintains Buy rating - Investing.com Canada

Mar 03, 2025

New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection - Yahoo Finance

Mar 03, 2025

Personalis’ (PSNL) “Buy” Rating Reiterated at HC Wainwright - Defense World

Mar 03, 2025

Needham & Company LLC Cuts Personalis (NASDAQ:PSNL) Price Target to $7.00 - Defense World

Mar 03, 2025

Mar 02, 2025

Personalis, Inc. (NASDAQ:PSNL) Just Reported Earnings, And Analysts Cut Their Target Price - Simply Wall St

Mar 02, 2025

Mar 01, 2025

Personalis (NASDAQ:PSNL) Price Target Lowered to $7.00 at Needham & Company LLC - MarketBeat

Mar 01, 2025

Personalis Full Year 2024 Earnings: Beats Expectations - Yahoo Finance UK

Mar 01, 2025

Feb 28, 2025

Personalis (NASDAQ:PSNL) Announces Quarterly Earnings Results - MarketBeat

Feb 28, 2025

Personalis stock target cut to $7.00 at Needham, retains buy rating By Investing.com - Investing.com South Africa

Feb 28, 2025

Personalis (NASDAQ:PSNL) Announces Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat

Feb 28, 2025

Personalis files to sell 14.04M shares of common stock for holders - MSN

Feb 28, 2025

Personalis stock target cut to $7.00 at Needham, retains buy rating - Investing.com Canada

Feb 28, 2025

Personalis, Inc. (NASDAQ:PSNL) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025

A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts - Benzinga

Feb 28, 2025